Back to Journals » Research and Reports in Urology » Volume 2

The role of high-dose chemotherapy in the treatment of testicular cancer

Authors Karadimou A, Dimopoulos MA, Bamias A

Published 10 February 2010 Volume 2010:2 Pages 25—30

DOI https://doi.org/10.2147/RRU.S6571

Review by Single-blind

Peer reviewer comments 2


Alexandra Karadimou, Meletios A Dimopoulos, Aristotle Bamias Dept of Clinical Therapeutics, University of Athens Medical School, Athens, Greece
Abstract: Testicular cancer is a highly curable neoplasm, even in the case of extragonadal disease. Nevertheless, patients with adverse prognostic features or relapsing after first-line cisplatin-based chemotherapy have a worse prognosis with a death rate greater than 50%. Highdose chemotherapy (HDC) has long been used in this group of patients. The introduction of stem cells, instead of bone marrow, as the source of hemopoietic cells and the use of leukocyte growth factors have substantially reduced the mortality and morbidity of this procedure although the role of HDC is not well defined. This review summarizes the available data, focusing on published randomized studies. The problems associated with the design of these studies and the interpretation of data are discussed. Currently this HDC approach is mainly used in patients who relapse after first-line chemotherapy. Nevertheless, selection of patients likely to benefit from this treatment remains an issue of intense clinical research.
Keywords: high-dose chemotherapy, testicular cancer, salvage therapy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]